122 related articles for article (PubMed ID: 1989796)
21. Amiodarone pneumonitis. Bronchoalveolar lavage findings in 15 patients and review of the literature.
Coudert B; Bailly F; Lombard JN; Andre F; Camus P
Chest; 1992 Oct; 102(4):1005-12. PubMed ID: 1395734
[TBL] [Abstract][Full Text] [Related]
22. Reduction of amiodarone pulmonary toxicity in patients treated with angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kosseifi SG; Halawa A; Bailey B; Micklewright M; Roy TM; Byrd RP
Ther Adv Respir Dis; 2009 Dec; 3(6):289-94. PubMed ID: 19850648
[TBL] [Abstract][Full Text] [Related]
23. [Diagnosis of lung injury due to amiodarone--contribution of bronchoalveolar lavage].
Kolek V; Dusek J; Dusková M; Václavík A; Vomácka Z
Vnitr Lek; 1990 Jan; 36(1):75-80. PubMed ID: 2327087
[TBL] [Abstract][Full Text] [Related]
24. A characterization of amiodarone-induced pulmonary toxicity in F344 rats and identification of surfactant protein-D as a potential biomarker for the development of the toxicity.
Taylor MD; Van Dyke K; Bowman LL; Miles PR; Hubbs AF; Mason RJ; Shannon K; Reasor MJ
Toxicol Appl Pharmacol; 2000 Sep; 167(3):182-90. PubMed ID: 10986009
[TBL] [Abstract][Full Text] [Related]
25. Amiodarone-induced acute lung toxicity in an ICU setting.
Skroubis G; Galiatsou E; Metafratzi Z; Karahaliou A; Kitsakos A; Nakos G
Acta Anaesthesiol Scand; 2005 Apr; 49(4):569-71. PubMed ID: 15777308
[TBL] [Abstract][Full Text] [Related]
26. T lymphocytes and silica-induced pulmonary inflammation and fibrosis in mice.
Suzuki N; Ohta K; Horiuchi T; Takizawa H; Ueda T; Kuwabara M; Shiga J; Ito K
Thorax; 1996 Oct; 51(10):1036-42. PubMed ID: 8977606
[TBL] [Abstract][Full Text] [Related]
27. [Cytology and phospholipid content of the bronchoalveolar lavage liquid in diffuse interstitial pneumopathies and in sarcoidosis. Apropos of 96 lavages].
Sallerin F; Prévost MC; De Graeve P; Miguères J; Krempf M; Jover A
Rev Mal Respir; 1984; 1(3):181-5. PubMed ID: 6473890
[TBL] [Abstract][Full Text] [Related]
28. Amiodarone-induced hypersensitivity pneumonitis. Evidence of an immunological cell-mediated mechanism.
Akoun GM; Gauthier-Rahman S; Milleron BJ; Perrot JY; Mayaud CM
Chest; 1984 Jan; 85(1):133-5. PubMed ID: 6606534
[TBL] [Abstract][Full Text] [Related]
29. Bronchoalveolar lavage cell data in amiodarone-associated pneumonitis. Evaluation in 22 patients.
Akoun GM; Cadranel JL; Blanchette G; Milleron BJ; Mayaud CM
Chest; 1991 May; 99(5):1177-82. PubMed ID: 1673380
[TBL] [Abstract][Full Text] [Related]
30. Amiodarone pulmonary toxicity: clinical and subclinical features.
Adams PC; Gibson GJ; Morley AR; Wright AJ; Corris PA; Reid DS; Campbell RW
Q J Med; 1986 May; 59(229):449-71. PubMed ID: 3763811
[TBL] [Abstract][Full Text] [Related]
31. Idiopathic pulmonary fibrosis. Abnormalities in the bronchoalveolar lavage content of surfactant protein A.
McCormack FX; King TE; Voelker DR; Robinson PC; Mason RJ
Am Rev Respir Dis; 1991 Jul; 144(1):160-6. PubMed ID: 2064123
[TBL] [Abstract][Full Text] [Related]
32. Amiodarone-induced pulmonary toxicity in the rat.
Wilson BD; Jaworski AJ; Donner ME; Lippmann ML
Lung; 1989; 167(5):301-11. PubMed ID: 2507834
[TBL] [Abstract][Full Text] [Related]
33. Pulmonary accumulation of amiodarone and N-desethylamiodarone. Relationship to the development of pulmonary toxicity.
Wilson BD; Lippmann ML
Am Rev Respir Dis; 1990 Jun; 141(6):1553-8. PubMed ID: 2350098
[TBL] [Abstract][Full Text] [Related]
34. Idiopathic pulmonary fibrosis. Abnormalities in bronchoalveolar lavage fluid phospholipids.
Robinson PC; Watters LC; King TE; Mason RJ
Am Rev Respir Dis; 1988 Mar; 137(3):585-91. PubMed ID: 3345040
[TBL] [Abstract][Full Text] [Related]
35. Amiodarone-associated pulmonary toxicity. A clinical and pathologic study of eleven cases.
Dean PJ; Groshart KD; Porterfield JG; Iansmith DH; Golden EB
Am J Clin Pathol; 1987 Jan; 87(1):7-13. PubMed ID: 3799544
[TBL] [Abstract][Full Text] [Related]
36. Acute pulmonary toxicity in an infant from intravenous amiodarone.
Daniels CJ; Schutte DA; Hammond S; Franklin WH
Am J Cardiol; 1997 Oct; 80(8):1113-6. PubMed ID: 9352994
[TBL] [Abstract][Full Text] [Related]
37. Pulmonary toxicity from amiodarone.
Stover DE
N Y State J Med; 1991 Sep; 91(9):384-5. PubMed ID: 1945148
[No Abstract] [Full Text] [Related]
38. Pulmonary masses in a patient with blue-gray cutaneous hyperpigmentation.
Facchini G; Forte S; Podda P; Piro F; Carlone S
Eur Rev Med Pharmacol Sci; 2008; 12(2):113-6. PubMed ID: 18575161
[TBL] [Abstract][Full Text] [Related]
39. Amiodarone pulmonary toxicity. Recognition and pathogenesis (Part I).
Martin WJ; Rosenow EC
Chest; 1988 May; 93(5):1067-75. PubMed ID: 3282816
[TBL] [Abstract][Full Text] [Related]
40. Gallium lung scintigraphy in amiodarone pulmonary toxicity.
Zhu YY; Botvinick E; Dae M; Golden J; Hattner R; Scheinman M
Chest; 1988 Jun; 93(6):1126-31. PubMed ID: 3371091
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
